ArticleCureus2026
Conservative Management of Invasive Group A Streptococcal Infection With Cervical Necrotizing Fasciitis-Spectrum Disease and Pneumonia in a Healthy Young Adult.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Invasive Group A streptococcal (iGAS) infections are life-threatening conditions classically manifesting as necrotizing fasciitis or severe pneumonia, but their simultaneous occurrence in a previously healthy adult is extremely rare. While necrotizing fasciitis typically mandates urgent surgery, this report highlights a case of concurrent cervical necrotizing fasciitis-spectrum disease and pneumonia successfully managed through a conservative, non-surgical approach. A 29-year-old previously healthy Japanese male presented with a two-day history of fever, sore throat, and a maculopapular rash, with a throat swab positive for GAS. On Day 2, he acutely developed progressive dyspnea, hypoxemia, and extensive cervical subcutaneous emphysema. Computed tomography confirmed diffuse fascial edema and bilateral pulmonary infiltrates without signs of gas-forming abscess or irreversible tissue necrosis. Despite early amoxicillin administration, blood cultures remained negative, suggesting toxin-mediated clinical deterioration. Based on the imaging findings and close clinical monitoring, a non-operative strategy was selected. This was achieved by immediate medical escalation to broad-spectrum antimicrobials, including clindamycin to suppress toxin production, alongside meropenem and high-dose penicillin G. The patient recovered fully without surgical intervention. This case highlights that iGAS can cause rapid, concurrent soft-tissue and pulmonary involvement even in healthy individuals. In select cases of necrotizing fasciitis-spectrum disease where irreversible tissue necrosis is absent on prompt imaging and close clinical monitoring is maintained, aggressive multi-drug medical escalation incorporating antitoxin therapy can lead to successful outcomes without the need for morbid surgical procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.